======= NR3C1 ======= == Gene Information == * **Official Symbol**: NR3C1 * **Official Name**: nuclear receptor subfamily 3 group C member 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=2908|2908]] * **UniProt**: [[https://www.uniprot.org/uniprot/P04150|P04150]] * **Interactions**: [[https://thebiogrid.org/search.php?search=NR3C1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20NR3C1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/138040|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes glucocorticoid receptor, which can function both as a transcription factor that binds to glucocorticoid response elements in the promoters of glucocorticoid responsive genes to activate their transcription, and as a regulator of other transcription factors. This receptor is typically found in the cytoplasm, but upon ligand binding, is transported into the nucleus. It is involved in inflammatory responses, cellular proliferation, and differentiation in target tissues. Mutations in this gene are associated with generalized glucocorticoid resistance. Alternative splicing of this gene results in transcript variants encoding either the same or different isoforms. Additional isoforms resulting from the use of alternate in-frame translation initiation sites have also been described, and shown to be functional, displaying diverse cytoplasm-to-nucleus trafficking patterns and distinct transcriptional activities (PMID:15866175). [provided by RefSeq, Feb 2011]. * **UniProt Summary**: Receptor for glucocorticoids (GC) (PubMed:27120390). Has a dual mode of action: as a transcription factor that binds to glucocorticoid response elements (GRE), both for nuclear and mitochondrial DNA, and as a modulator of other transcription factors. Affects inflammatory responses, cellular proliferation and differentiation in target tissues. Involved in chromatin remodeling (PubMed:9590696). Plays a role in rapid mRNA degradation by binding to the 5' UTR of target mRNAs and interacting with PNRC2 in a ligand-dependent manner which recruits the RNA helicase UPF1 and the mRNA-decapping enzyme DCP1A, leading to RNA decay (PubMed:25775514). Could act as a coactivator for STAT5-dependent transcription upon growth hormone (GH) stimulation and could reveal an essential role of hepatic GR in the control of body growth (By similarity). {ECO:0000250|UniProtKB:P06537, ECO:0000269|PubMed:25775514, ECO:0000269|PubMed:27120390, ECO:0000269|PubMed:9590696}. Isoform Beta: Acts as a dominant negative inhibitor of isoform Alpha (PubMed:7769088, PubMed:8621628, PubMed:20484466). Has intrinsic transcriptional activity independent of isoform Alpha when both isoforms are coexpressed (PubMed:19248771, PubMed:26711253). Loses this transcription modulator function on its own (PubMed:20484466). Has no hormone-binding activity (PubMed:8621628). May play a role in controlling glucose metabolism by maintaining insulin sensitivity (By similarity). Reduces hepatic gluconeogenesis through down-regulation of PEPCK in an isoform Alpha-dependent manner (PubMed:26711253). Directly regulates STAT1 expression in isoform Alpha-independent manner (PubMed:26711253). {ECO:0000250|UniProtKB:P06537, ECO:0000269|PubMed:19248771, ECO:0000269|PubMed:20484466, ECO:0000269|PubMed:26711253, ECO:0000269|PubMed:7769088, ECO:0000269|PubMed:8621628}. Isoform GR-P: Increases activity of isoform Alpha. {ECO:0000269|PubMed:11358809}. Isoform 10: Has transcriptional activation activity. {ECO:0000269|PubMed:20484466}. Isoform Alpha-C2: Has transcriptional activation activity. {ECO:0000269|PubMed:15866175}. Isoform Alpha-D1: Has transcriptional activation activity. {ECO:0000269|PubMed:15866175}. Isoform Alpha-D3: Has lowest transcriptional activation activity of all isoforms created by alternative initiation (PubMed:15866175, PubMed:23820903). Has transcriptional repression activity (PubMed:23303127). {ECO:0000269|PubMed:15866175, ECO:0000269|PubMed:23303127, ECO:0000269|PubMed:23820903}. |GCR| |zf-C4| |Hormone recep| |glucocorticoid mediated signaling pathway| |glucocorticoid receptor activity| |steroid hormone binding| |glucocorticoid receptor signaling pathway| |corticosteroid receptor signaling pathway| |SUMO binding| |core promoter binding| |steroid binding| |cellular response to dexamethasone stimulus| |positive regulation of pri-miRNA transcription by RNA polymerase II| |response to dexamethasone| |Hsp90 protein binding| |regulation of pri-miRNA transcription by RNA polymerase II| |nuclear receptor activity| |cellular response to glucocorticoid stimulus| |cellular response to corticosteroid stimulus| |intracellular steroid hormone receptor signaling pathway| |cellular response to ketone| |response to antineoplastic agent| |steroid hormone mediated signaling pathway| |spindle| |response to glucocorticoid| |cellular response to transforming growth factor beta stimulus| |microtubule organizing center| |response to corticosteroid| |response to transforming growth factor beta| |intracellular receptor signaling pathway| |hormone-mediated signaling pathway| |transcription initiation from RNA polymerase II promoter| |cellular response to xenobiotic stimulus| |cellular response to steroid hormone stimulus| |response to ketone| |DNA-templated transcription, initiation| |chromosome segregation| |response to xenobiotic stimulus| |response to steroid hormone| |mitochondrial matrix| |nuclear speck| |cellular response to drug| |DNA-binding transcription activator activity, RNA polymerase II-specific| |protein kinase binding| |transcription by RNA polymerase II| |cell division| |cellular response to growth factor stimulus| |RNA polymerase II proximal promoter sequence-specific DNA binding| |cellular response to lipid| |response to growth factor| |cellular response to organic cyclic compound| |protein-containing complex| |cellular response to hormone stimulus| |transcription, DNA-templated| |nucleic acid-templated transcription| |RNA biosynthetic process| |DNA-binding transcription factor activity| |chromatin organization| |zinc ion binding| |response to lipid| |negative regulation of transcription by RNA polymerase II| |response to hormone| |response to organic cyclic compound| |apoptotic process| |response to drug| |programmed cell death| |cellular response to oxygen-containing compound| |chromosome organization| |cell death| |nucleobase-containing compound biosynthetic process| |heterocycle biosynthetic process| |aromatic compound biosynthetic process| |negative regulation of transcription, DNA-templated| |positive regulation of transcription by RNA polymerase II| |cellular response to endogenous stimulus| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |organic cyclic compound biosynthetic process| |negative regulation of RNA metabolic process| |cell cycle| |negative regulation of cellular macromolecule biosynthetic process| |RNA binding| |negative regulation of nucleobase-containing compound metabolic process| |negative regulation of macromolecule biosynthetic process| |response to endogenous stimulus| |negative regulation of cellular biosynthetic process| |positive regulation of transcription, DNA-templated| |negative regulation of biosynthetic process| |response to oxygen-containing compound| |DNA-binding transcription factor activity, RNA polymerase II-specific| |cellular nitrogen compound biosynthetic process| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |RNA metabolic process| |cellular macromolecule biosynthetic process| |negative regulation of gene expression| |positive regulation of RNA metabolic process| |macromolecule biosynthetic process| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp440|Aphidicolin 0.4μM R08 exp440]]|1.9| |[[:results:exp351|Dexamethasone 0.006μM R07 exp351]]|5.34| |[[:results:exp352|Dexamethasone 0.006 to 0.015μM on day4 R07 exp352]]|7.72| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 1/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 18139 * **Expression level (log2 read counts)**: 7.07 {{:chemogenomics:nalm6 dist.png?nolink |}}